Skip to main content

IM Cannabis Corp.

IMCC
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0001792030

No open-market purchases or sales by IM Cannabis Corp. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $62.0K in total; no superinvestor holds it.

Holders of 5% or more of IMCC

Holders whose latest Schedule 13D or 13G filing reports 5% or more of IM Cannabis Corp., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of IM Cannabis Corp. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

5 Schedule 13D and 13G filings on IM Cannabis Corp., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on IMCC
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 21, 2023Luminera Derm Ltd.13GOld format–New–SEC
Feb 8, 2023Shuster Oren13D/AOld format–––SEC
Feb 2, 2023Gabay Rafael Rifat13G/AOld format–––SEC
Feb 16, 2022Gabay Rafael Rifat13GOld format–New–SEC
Feb 14, 2022Shuster Oren13DOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell IM Cannabis Corp. shares.

No Form 144 notices for IM Cannabis Corp. are on file.